Chennai Meenakshi Multispeciality Hospital Limited (BOM:523489)
India · Delayed Price · Currency is INR 36.61
+0.01 (0.03%)
At close: Oct 1, 2026
BOM:523489 Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 369.8 | 370.39 | 348.19 | 382.03 | 387.41 | 313.86 | |
Revenue Growth | 6.51% | 6.38% | -8.86% | -1.39% | 23.43% | 61.10% |
Cost of Revenue | 165.83 | 181.27 | 169.6 | 180.5 | 175.51 | 171.26 |
Gross Profit | 203.97 | 189.12 | 178.59 | 201.53 | 211.9 | 142.6 |
Selling, General & Admin | - | 9.62 | 10.11 | 9.8 | 8.92 | 8.13 |
Other Operating Expenses | 198.1 | 178.68 | 170.24 | 172.79 | 172.56 | 77.02 |
Operating Expenses | 208.68 | 199.82 | 192.26 | 194.15 | 193.39 | 96.89 |
Operating Income | -4.71 | -10.7 | -13.67 | 7.39 | 18.52 | 45.72 |
Interest Expense | -8.98 | -7.45 | -7.72 | -7.59 | -7.45 | -7.72 |
Interest & Investment Income | - | 3.23 | 2.68 | 2.04 | 1.64 | 0.77 |
Other Non Operating Income (Expenses) | 9.62 | 6.41 | 4.44 | 1.08 | 0.41 | 0.99 |
EBT Excluding Unusual Items | -4.06 | -8.5 | -14.27 | 2.92 | 13.12 | 39.76 |
Gain (Loss) on Sale of Assets | - | - | - | -1.88 | -0.31 | - |
Pretax Income | -4.06 | -8.5 | -14.27 | 1.04 | 12.81 | 39.76 |
Income Tax Expense | -0.33 | 2.67 | -0.53 | 5.31 | 3.9 | - |
Net Income | -3.73 | -11.17 | -13.74 | -4.27 | 8.91 | 39.76 |
Net Income to Common | -3.73 | -11.17 | -13.74 | -4.27 | 8.91 | 39.76 |
Net Income Growth | - | - | - | - | -77.60% | - |
Shares Outstanding (Basic) | - | 7 | 7 | 7 | 7 | 7 |
Shares Outstanding (Diluted) | - | 7 | 7 | 7 | 7 | 7 |
Shares Change | - | - | - | - | -0.00% | 0.00% |
EPS (Basic) | - | -1.50 | -1.84 | -0.57 | 1.19 | 5.32 |
EPS (Diluted) | - | -1.50 | -1.84 | -0.57 | 1.19 | 5.32 |
EPS Growth | - | - | - | - | -77.63% | - |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | - | 2.67 | 19.01 | -1.17 | 18.61 | 15.6 |
Free Cash Flow Per Share | - | 0.36 | 2.54 | -0.16 | 2.49 | 2.09 |
Gross Margin | 55.16% | 51.06% | 51.29% | 52.75% | 54.70% | 45.43% |
Operating Margin | -1.27% | -2.89% | -3.93% | 1.93% | 4.78% | 14.57% |
Profit Margin | -1.01% | -3.02% | -3.94% | -1.12% | 2.30% | 12.67% |
Free Cash Flow Margin | - | 0.72% | 5.46% | -0.31% | 4.80% | 4.97% |
EBITDA | 6.02 | 0.21 | -2.04 | 18.95 | 30.32 | 57.45 |
EBITDA Margin | 1.63% | 0.06% | -0.58% | 4.96% | 7.83% | 18.30% |
D&A For EBITDA | 10.73 | 10.9 | 11.63 | 11.56 | 11.8 | 11.73 |
EBIT | -4.71 | -10.7 | -13.67 | 7.39 | 18.52 | 45.72 |
EBIT Margin | -1.27% | -2.89% | -3.93% | 1.93% | 4.78% | 14.57% |
Effective Tax Rate | - | - | - | 511.75% | 30.46% | - |
Revenue as Reported | 379.42 | 381.57 | 356.72 | 386.75 | 390.94 | 317.75 |
Advertising Expenses | - | 0.18 | 0.28 | 0.41 | 0.33 | 0.33 |